Alembic Ltd.
BSE: 506235 | Sector: Health care |
NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
BSE 00:00 | 31 Jan | 68.75 |
1.55 (2.31%) |
OPEN
68.85 |
HIGH
69.20 |
LOW
67.20 |
NSE 00:00 | 31 Jan | 68.75 |
1.60 (2.38%) |
OPEN
67.75 |
HIGH
69.30 |
LOW
67.20 |
OPEN | 68.85 |
PREVIOUS CLOSE | 67.20 |
VOLUME | 17269 |
52-Week high | 102.85 |
52-Week low | 56.50 |
P/E | 24.12 |
Mkt Cap.(Rs cr) | 1,766 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Alembic Ltd. (ALEMBICLTD) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 1,035.00 | 248,327.54 | 15,585.98 | -99.99 | 30,678.37 |
Divi's Lab. | 3,317.45 | 88,061.71 | 8,879.82 | 2,948.54 | 11,718.06 |
Cipla | 1,017.00 | 82,087.15 | 13,091.79 | 2,957.93 | 22,671.86 |
Dr Reddy's Labs | 4,324.00 | 72,003.25 | 14,405.20 | 1,623.20 | 20,636.20 |
Apollo Hospitals | 4,255.55 | 61,186.30 | 6,098.30 | 665.20 | 8,868.60 |
Torrent Pharma. | 1,521.45 | 51,491.95 | 6,742.32 | 991.45 | 9,910.76 |
Abbott India | 20,842.40 | 44,290.10 | 4,919.27 | 798.70 | 3,063.88 |
Zydus Lifesci. | 430.75 | 43,600.52 | 7,981.90 | 857.90 | 16,096.50 |
Max Healthcare | 441.10 | 42,823.75 | 1,800.06 | 331.13 | 6,780.23 |
Alkem Lab | 3,009.75 | 35,981.56 | 8,829.81 | 1,541.25 | 11,301.35 |
Lupin | 737.95 | 33,569.35 | 11,771.67 | -188.70 | 19,439.28 |
Biocon | 235.10 | 28,226.11 | 1,738.20 | 86.10 | 8,279.00 |
Aurobindo Pharma | 408.30 | 23,922.30 | 11,287.14 | 1,454.71 | 19,017.26 |
Syngene Intl. | 563.70 | 22,628.61 | 2,601.40 | 393.80 | 4,609.20 |
Ipca Labs. | 850.15 | 21,568.31 | 5,399.36 | 870.94 | 6,342.72 |
Gland Pharma | 1,300.20 | 21,414.29 | 4,400.71 | 1,212.16 | 7,164.70 |
Fortis Health. | 281.90 | 21,282.32 | 895.63 | -13.25 | 10,080.65 |
Glaxosmi. Pharma | 1,246.70 | 21,120.35 | 3,217.51 | 1,690.53 | 2,948.24 |
Laurus Labs | 330.40 | 17,797.00 | 4,707.04 | 750.09 | 5,178.13 |
Pfizer | 3,871.85 | 17,713.71 | 2,610.99 | 612.56 | 3,086.87 |
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices